Analytical Methodology for Biological Monitoring of Chromium

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 1 I, 1997, Pages

  Harzdorf, C ^a   Lewalter, J ^b  

^a Business Group Inorganics

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHROMIUM; CHROMIUM DERIVATIVE;

BIOLOGICAL MONITORING; BODY FLUID; CONFERENCE PAPER; HUMAN; INTOXICATION; POTENTIOMETRY; PRIORITY JOURNAL;

ANIMALS; CHROMIUM; CHROMIUM COMPOUNDS; ENVIRONMENTAL MONITORING; HUMANS;

EID: 0030810591     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1145     Document Type: Article

References (16)

1. Bolt, H. M., and Lewalter, J. (1988). Alkali chromates. In Biological Exposure Values for Occupational Toxicants, pp. 187-203. Deutsche Forschungsgemeinschaft.
2. Connett, P. H., and Wetterhahn, K. E. (1985). In vitro reaction of chromate with thiols and carboxylic acids. J. Am. Chem. Soc. 107, 4282-4288.
3. Fishbein, L. (1987). Perspectives of analysis of carcinogenic and mu-tagenic metals in biological samples. Int. J. Environ. Anal. Chem. 28, 21-96.
4. deFlora, S., and Wetterhahn, K. E. (1989). Mechanism of chromium metabolism and genotoxicity. Life. Chem. Rep. 7, 169-244.
5. Guthrie, B. E., et al. (1987). Background correction and related problems in the determination of chromium in urine by graphite furnace atomic absorption spectrometry. Anal. Chem. 50, 1900-1902.
6. Korallus, U., et al. (1984). Experimental bases for ascorbic acid therapy of poisoning by hexavalent chromium compounds. Int. Arch. Occup. Health 53, 247-256.
7. Lewalter, J., et al. (1991). Chromium determination in whole blood, plasma and erythrocytes. Anal. Hazard. Subst. Biol. Mater. 3, 109-113.
8. Lewalter, J., et al. (1985). Chromium bond detection in isolated erythrocytes: A new principle of biological monitoring of exposure to hexavalent chromium. Int. Arch. Occup. Environ. Health 55, 305-318.
9. Parr, R. M. (1977). Problems of chromium analysis in biological materials: An international perspective with special reference to results for analytical quality control samples. J. Radioanal. Chem. 39, 421-433.
10. Petrilli, F., and deFlora, S. (1978). Metabolic deactivation of hexavalent chromium mutagenicity. Mutat. Res. 54, 139-147.
11. Poppel, W. J., et al. (1963). Effect of ascorbic acid in vivo on labeling of red cells by radioactive sodium chromate. Blood 22, 351-356.
12. Samitz, U. H., et al. (1962). Studies on the prevention of injurious effects of chromates in industry. Int. Med. Surg. 31, 427-432.
13. Slavin, W. (1981). Determination of chromium in the environment and in the workplace. At. Spectros. 2, 8-12.
14. U.S. Environmental Protection Agency (1983). Assessment Document for Chromium, Doc. No. 600/8-83-014A, Chap. 3, pp. 35-36.
15. Versieck, J. M. J., and Cornells, R. (1980). Normal levels of trace elements in human blood plasma and serum. Anal. Chim. Acta 116, 217-254.
16. Wiegand, H. J., et al. (1985). Fast uptake kinetics in vitro of chromium-51(VI) by red blood cells of man and rat. Arch. Toxicol. 57, 31-34.